{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:45:56Z","timestamp":1783637156646,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T00:00:00Z","timestamp":1640736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.yebeh.2021.108529","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T05:03:26Z","timestamp":1641618206000},"page":"108529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Patient preferences pertaining to treatment options for drug-resistant focal epilepsy"],"prefix":"10.1016","volume":"127","author":[{"given":"Saurabh R.","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Reed","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby D.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108529_b0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0010","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jama.2012.220","article-title":"Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial","volume":"307","author":"Engel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2021.108529_b0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM200108023450501","article-title":"A randomized, controlled trial of surgery for temporal-lobe epilepsy","volume":"345","author":"Wiebe","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2021.108529_b0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0b013e318250d7ea","article-title":"Epilepsy surgery trends in the United States, 1990\u20132008","volume":"78","author":"Englot","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108529_b0025","doi-asserted-by":"crossref","first-page":"107837","DOI":"10.1016\/j.yebeh.2021.107837","article-title":"Underutilization of epilepsy surgery: Part I: A scoping review of barriers","volume":"117","author":"Samanta","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.14634","article-title":"Safety and effectiveness of stereotactic laser ablation for epileptogenic cerebral cavernous malformations","volume":"60","author":"Willie","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/WCO.0000000000000662","article-title":"Laser interstitial thermal therapy in drug-resistant epilepsy","volume":"32","author":"Shimamoto","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2021.108529_b0040","doi-asserted-by":"crossref","DOI":"10.1111\/epi.15565","article-title":"Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: a multicenter study of 234 patients","author":"Wu","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.wneu.2020.07.194","article-title":"Surgical outcomes of laser interstitial thermal therapy for temporal lobe epilepsy: systematic review and meta-analysis","volume":"143","author":"Kerezoudis","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1016\/j.yebeh.2021.108529_b0050","doi-asserted-by":"crossref","first-page":"106473","DOI":"10.1016\/j.eplepsyres.2020.106473","article-title":"A prospective multicenter study of laser ablation for drug resistant epilepsy - One year outcomes","volume":"167","author":"Landazuri","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108529_b0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yebeh.2015.07.022","article-title":"Laser ablation therapy: an alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50","volume":"51","author":"Waseem","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0060","doi-asserted-by":"crossref","first-page":"e1303","DOI":"10.1212\/WNL.0000000000008940","article-title":"Visual field deficits following laser ablation of the hippocampus","volume":"94","author":"Donos","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108529_b0065","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1212\/CPJ.0000000000000728","article-title":"Cognitive outcomes following laser interstitial therapy for mesiotemporal epilepsies","volume":"10","author":"Bermudez","year":"2020","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.yebeh.2021.108529_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/epi.12860","article-title":"Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy","volume":"56","author":"Drane","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0075","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/epi.14443","article-title":"Laser ablation for mesial temporal lobe epilepsy: Surgical and cognitive outcomes with and without mesial temporal sclerosis","volume":"59","author":"Donos","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0080","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/epi.16529","article-title":"Stereotactic laser ablation for mesial temporal lobe epilepsy: a prospective, multicenter, single-arm study","volume":"61","author":"Sperling","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.yebeh.2012.05.020","article-title":"Patients' preferences for treatment outcomes of add-on antiepileptic drugs: a conjoint analysis","volume":"24","author":"Manjunath","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yebeh.2017.11.015","article-title":"A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs","volume":"79","author":"Atkinson-Clark","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2013.11.029","article-title":"Eliciting patients' preferences for epilepsy diagnostics: a discrete choice experiment","volume":"31","author":"Wijnen","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0100","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/bcp.12715","article-title":"Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery","volume":"80","author":"Powell","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2021.108529_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","article-title":"Conjoint analysis applications in health - a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.yebeh.2021.108529_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.yebeh.2021.108529_b0115","unstructured":"US Food and Drug Administration, Center for Devices & Radiological Health and Center for Biologics Evaluation & Research. Factors to consider when making benefit-risk determinations in medical device premarket approval and de novo classifications: Guidance for industry and Food and Drug Administration staff, https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/factors-consider-when-making-benefit-risk-determinations-medical-device-premarket-approval-and-de. 2012."},{"key":"10.1016\/j.yebeh.2021.108529_b0120","unstructured":"US Food and Drug Administration. Patient preference information - voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling: Guidance for industry, Food and Drug Administration Staff, and other stakeholders, https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-preference-information-voluntary-submission-review-premarket-approval-applications. 2016."},{"key":"10.1016\/j.yebeh.2021.108529_b0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jval.2018.07.876","article-title":"The internal validity of discrete choice experiment data: a testing tool for quantitative assessments","volume":"22","author":"Johnson","year":"2019","journal-title":"Value Health"},{"issue":"18","key":"10.1016\/j.yebeh.2021.108529_b0130","first-page":"1","article-title":"Small-sample properties of tests for heteroscedasticity in the conditional logit model","volume":"3","author":"Hole","year":"2006","journal-title":"Econ Bull"},{"key":"10.1016\/j.yebeh.2021.108529_b0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jtrangeo.2007.07.001","article-title":"Combining RP and SP data: biases in using the nested logit \u2018trick\u2019 \u2013 contrasts with flexible mixed logit incorporating panel and scale effects","volume":"16","author":"Hensher","year":"2008","journal-title":"J Transp Geogr"},{"key":"10.1016\/j.yebeh.2021.108529_b0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2307\/1924536","article-title":"On approximating the statistical properties of elasticities","volume":"68","author":"Krinsky","year":"1986","journal-title":"Rev Econ Stat"},{"key":"10.1016\/j.yebeh.2021.108529_b0145","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2008.771","article-title":"Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis","volume":"300","author":"Choi","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2021.108529_b0150","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1528-1167.2011.03020.x","article-title":"Preference-based quality-of-life measures for neocortical epilepsy surgery","volume":"52","author":"Knowlton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/epi.14641","article-title":"Referral to evaluation for epilepsy surgery: reluctance by epileptologists and patients","volume":"60","author":"Steinbrenner","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/epi.13284","article-title":"Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy","volume":"57","author":"Kang","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108529_b0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3171\/2019.4.JNS183235","article-title":"A historical cohort of temporal lobe surgery for medically refractory epilepsy: a systematic review and meta-analysis to guide future nonrandomized controlled trial studies","volume":"133","author":"Lee","year":"2020","journal-title":"J Neurosurg"},{"key":"10.1016\/j.yebeh.2021.108529_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2018.09.040","article-title":"Laser interstitial thermal therapy (LITT): seizure outcomes for refractory mesial temporal lobe epilepsy","volume":"89","author":"Le","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108529_b0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.25180","article-title":"Stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy","volume":"83","author":"Gross","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2021.108529_b0180","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eplepsyres.2017.09.016","article-title":"MRI-guided stereotactic laser ablation for epilepsy surgery: promising preliminary results for cognitive outcome","volume":"142","author":"Drane","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108529_b0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000502701","article-title":"Mechanisms and risk factors contributing to visual field deficits following stereotactic laser amygdalohippocampotomy","volume":"97","author":"Voets","year":"2019","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.yebeh.2021.108529_b0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yebeh.2018.01.025","article-title":"Patient versus neurologist preferences: a discrete choice experiment for antiepileptic drug therapies","volume":"80","author":"Ettinger","year":"2018","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021007903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021007903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:44:08Z","timestamp":1761504248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021007903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":38,"alternative-id":["S1525505021007903"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108529","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient preferences pertaining to treatment options for drug-resistant focal epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108529"}}